Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Extracellular vesicle measurements with nanoparticle tracking analysis - An accuracy and repeatability comparison between NanoSight NS300 and ZetaView.
Bachurski D, Schuldner M, Nguyen PH, Malz A, Reiners KS, Grenzi PC, Babatz F, Schauss AC, Hansen HP, Hallek M, Pogge von Strandmann E. Bachurski D, et al. Among authors: hansen hp. J Extracell Vesicles. 2019 Apr 1;8(1):1596016. doi: 10.1080/20013078.2019.1596016. eCollection 2019. J Extracell Vesicles. 2019. PMID: 30988894 Free PMC article.
RIG-I activation induces the release of extracellular vesicles with antitumor activity.
Daßler-Plenker J, Reiners KS, van den Boorn JG, Hansen HP, Putschli B, Barnert S, Schuberth-Wagner C, Schubert R, Tüting T, Hallek M, Schlee M, Hartmann G, Pogge von Strandmann E, Coch C. Daßler-Plenker J, et al. Among authors: hansen hp. Oncoimmunology. 2016 Aug 19;5(10):e1219827. doi: 10.1080/2162402X.2016.1219827. eCollection 2016. Oncoimmunology. 2016. PMID: 27853642 Free PMC article.
CD30-Positive Extracellular Vesicles Enable the Targeting of CD30-Negative DLBCL Cells by the CD30 Antibody-Drug Conjugate Brentuximab Vedotin.
Lobastova L, Lettau M, Babatz F, de Oliveira TD, Nguyen PH, Pauletti BA, Schauss AC, Dürkop H, Janssen O, Paes Leme AF, Hallek M, Hansen HP. Lobastova L, et al. Among authors: hansen hp. Front Cell Dev Biol. 2021 Jul 30;9:698503. doi: 10.3389/fcell.2021.698503. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34395429 Free PMC article.
Mono- and dual-targeting triplebodies activate natural killer cells and have anti-tumor activity in vitro and in vivo against chronic lymphocytic leukemia.
Vyas M, Schneider AC, Shatnyeva O, Reiners KS, Tawadros S, Kloess S, Köhl U, Hallek M, Hansen HP, Pogge von Strandmann E. Vyas M, et al. Among authors: hansen hp. Oncoimmunology. 2016 Jul 15;5(9):e1211220. doi: 10.1080/2162402X.2016.1211220. eCollection 2016. Oncoimmunology. 2016. PMID: 27757305 Free PMC article.
Extracellular vesicles released from chronic lymphocytic leukemia cells exhibit a disease relevant mRNA signature and transfer mRNA to bystander cells.
Reiners KS, Shatnyeva O, Vasyutina E, Bösl T, Hansen HP, Hallek M, Herling M, von Strandmann EP. Reiners KS, et al. Among authors: hansen hp. Haematologica. 2017 Mar;102(3):e100-e103. doi: 10.3324/haematol.2016.153197. Epub 2016 Nov 17. Haematologica. 2017. PMID: 27856511 Free PMC article. No abstract available.
Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53.
Schuldner M, Dörsam B, Shatnyeva O, Reiners KS, Kubarenko A, Hansen HP, Finkernagel F, Roth K, Theurich S, Nist A, Stiewe T, Paschen A, Knittel G, Reinhardt HC, Müller R, Hallek M, von Strandmann EP. Schuldner M, et al. Among authors: hansen hp. Theranostics. 2019 Aug 14;9(21):6047-6062. doi: 10.7150/thno.36378. eCollection 2019. Theranostics. 2019. PMID: 31534536 Free PMC article.
149 results